Discontinuation report TARO-DIPYRIDAMOLE/ ASA
| Report ID | 237043 |
| Drug Identification Number | 02471051 |
| Brand name | TARO-DIPYRIDAMOLE/ ASA |
| Common or Proper name | Dipyridamole |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETYLSALICYLIC ACID DIPYRIDAMOLE |
| Strength(s) | 25MG 200MG |
| Dosage form(s) | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 200mg |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2024-07-30 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-09-09 | French | Compare |
| v2 | 2024-09-09 | English | Compare |
| v1 | 2024-09-09 | English | Compare |
Showing 1 to 3 of 3